Moderna held further discussions with regulators and announced that the agency would accept the company’s application for approval of its flu vaccine that uses mRNA technology.Moderna held further discussions with regulators and announced that the agency would accept the company’s application for approval of its flu vaccine that uses mRNA technology. Drugs (Pharmaceuticals), Vaccination and Immunization, Regulation and Deregulation of Industry, Influenza, RNA (Ribonucleic Acid), Medicine and Health, Coronavirus (2019-nCoV), Food and Drug Administration, Moderna Inc, Health and Human Services Department, Kennedy, Robert F Jr Read More
F.D.A. Reverses Decision and Agrees to Review Moderna’s Flu Vaccine
